Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
"Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pituitary adenylate cyclase-activating peptide receptor subtype that is found in the HYPOTHALAMUS; BRAIN STEM; PITUITARY GLAND; ADRENAL GLAND; PANCREAS; and TESTES and has a high affinity only for PACAP.
MeSH Number(s)
D12.776.543.750.100.665.500
Concept/Terms
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
- PACAP Type I Receptor
- PAC1 Receptor
- Pituitary Adenylate Cyclase-Activating Peptide Receptor Type I
- Pituitary Adenylate Cyclase Activating Peptide Receptor Type I
- PACAP Receptors, Type I
- PACAPR-1 Protein
- PACAPR 1 Protein
Below are MeSH descriptors whose meaning is more general than "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I".
This graph shows the total number of publications written about "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 2 | 4 |
| 2017 | 0 | 1 | 1 |
| 2020 | 1 | 2 | 3 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I" by people in Profiles.
-
PACAP-PAC1R modulates fear extinction via the ventromedial hypothalamus. Nat Commun. 2022 07 28; 13(1):4374.
-
A brainstem peptide system activated at birth protects postnatal breathing. Nature. 2021 01; 589(7842):426-430.
-
Impact of ADCYAP1R1 genotype on longitudinal fear conditioning in children: interaction with trauma and sex. Neuropsychopharmacology. 2020 09; 45(10):1603-1608.
-
Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study. Neuropsychopharmacology. 2020 06; 45(7):1125-1133.
-
PACAP38 in human models of primary headaches. J Headache Pain. 2017 Nov 23; 18(1):110.
-
Functional evaluation of a PTSD-associated genetic variant: estradiol regulation and ADCYAP1R1. Transl Psychiatry. 2016 12 13; 6(12):e978.
-
Stress-related disorders, pituitary adenylate cyclase-activating peptide (PACAP)ergic system, and sex differences. Dialogues Clin Neurosci. 2016 12; 18(4):403-413.
-
Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain. Biol Psychiatry. 2017 04 15; 81(8):671-682.
-
Pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nucleus of the amygdala induces anxiety via melanocortin receptors. Psychopharmacology (Berl). 2016 Sep; 233(17):3269-77.
-
Gene-by-social-environment interaction (GxSE) between ADCYAP1R1 genotype and neighborhood crime predicts major depression symptoms in trauma-exposed women. J Affect Disord. 2015 Nov 15; 187:147-50.